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INTRODUCTION
Limb-girdle muscular dystrophies (LGMD) are hereditary pro-
gressive myopathy disorders presenting with predominant 
weakness of axial and proximal muscles. Among them, LGMD 
type 1D (LGMD1D) is a disease caused by mutation in the DNA-
JB6 gene.1 LGMD1D is characterized by an onset in adults and 
slow progression, although a few patients do have symptoms 
in their childhood. Limb-girdle muscle weakness with wad-
dling gait is common, and most patients have slightly elevated 
serum creatine kinase (CK) levels. Muscle biopsy typically 
shows rimmed vacuoles in skeletal muscle.2 Here, we describe 
three patients with LGMD1D from two families. One patient 
was found to have LGMD1D mutation (p.Phe89Ile) by whole 
axon sequencing analysis, while the other two patients were 
found to have p.Phe100Ile missense mutation by targeted se-
quencing.
CASE REPORT
This study has been approved by the Institutional Review Board 
(IRB) of Gangnam Severance Hospital (IRB no. 2015-0529-004).
Patient 1 from family 1
A 56-year-old woman (patient 1) visited the neurology outpa-
tient clinic due to lower extremity weakness. She had experi-
enced minimal weakness in limb-girdle muscles during her 
4th decade, and these symptoms had slowly deteriorated over 
20 years. Neurological examination revealed bilateral symmet-
ric weakness of limb-girdle muscles. The patient’s limb-girdle 
muscle strength was grade 4 under the Medical Research 
Council (MRC) system, and her distal muscle strength was al-
most normal. She could also walk independently with no symp-
toms of dysarthria, dysphagia, or dyspnea. Electrocardiogram 
showed normal sinus rhythm, and she had no cardiac symp-
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Limb-girdle muscular dystrophies (LGMD) are heterogeneous disorders with autosomal inheritance. Autosomal dominant 
LGMD mapped to 7q36.3 has been classified as LGMD type 1D (LGMD1D) in the Human Gene Nomenclature Committee Data-
base. LGMD1D is characterized predominantly by limb-girdle weakness and may also show a bulbar symptom in some cases. In 
the past, the frequency of this disease was uncommon, and this disorder was mainly found in Europe and the United States. 
However, recently, this disorder has been reported in Asia, including Japan, Korea, and Taiwan. Here, we report on three LG-
MD1D patients, including one with a novel mutation in DNAJB6, c.298T>A. While two patients complained of limb-girdle weak-
ness, as would be expected, one patient had distal weakness. They had various serum creatine kinase levels. Radiologic findings 
in one patient showed fatty degeneration and atrophy in the posterior part of distal muscles. Pathologic findings in one of the pa-
tients showed rimmed vacuoles. Although LGMD1D is still uncommon in Korea, we discovered three Korean patients with LG-
MD1D, including one novel mutation in DNAJB6, p.Phe100Ile (c.298T>A).
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toms. Laboratory findings showed normal serum CK levels 
(175 U/L) and electromyography showed myopathic changes. 
On leg magnetic resonance imaging, moderate fatty change 
was noted in the tibialis posterior and gastrocnemius (Fig. 1A). 
Her father (Fig. 2A) had suffered from the same symptoms, 
and her son also had similar symptoms. Whole exon sequenc-
ing was performed and revealed a heterozygous missense 
mutation (c.265T>A, p.Phe89Ile) in DNAJB6 (Fig. 2B). 
 
Patients 2 and 3 from family 2
A 31-year-old man (patient 2) visited a neurologist because of 
bilateral lower extremity weakness. He reported not running 
well since childhood, although he lived without any problems 
in his daily life. For a year before visiting the hospital, he had 
difficulty climbing stairs and needed a handrail when climb-
ing them. On physical examination, bilateral atrophy of the 
thigh muscles was seen, and toe gait or heel gait seemed to 
pose difficulty. He had no signs of dysarthria or dysphagia or 
any cardiac symptoms. Laboratory tests showed mild eleva-
tion of CK (613 U/L), and myopathic findings were found on 
electromyography.
The father of patient 2, a 63-year-old man (patient 3), suf-
fered from leg weakness since he was 17 years of age. When he 
visited our hospital at the age of 37 years, he showed promi-
nent lower extremity weakness and mild weakness of the up-
per extremity. Ten years later he was unable to walk, and dys-
arthria and dysphagia had emerged. The patient’s distal lower 
extremity muscle strengths were MRC grade 1, whereas his 
hip muscle strengths were rated between MRC grades 2 and 3. 
Likewise, distal muscles in upper extremities showed more 
pronounced weakness than proximal muscles. Electromyogra-
phy showed brief short motor unit action potentials in multi-
ple muscles. His muscle pathologic study showed myopathic 
features with rimmed vacuoles (Fig. 1B).
At the age of 63, he and his son (patient 2) visited our clinic 
and were confirmed for a novel missense mutation in DNA-
JB6 gene, c.298T>A (p.Phe100Ile) by a targeted next generation 
sequencing with 194 genes associated with muscular dystro-
phies (Fig. 2C). 
DISCUSSION
LGMD1D is linked to chromosome 7q36.3 with a change in 
exon 5 of DNAJB6. It is characterized by progressive proximal 
muscle weakness, even though one family showed distal domi-
nant weakness.2 Some reported studies have shown similar 
symptoms regardless of ethnicity or genetic variants. In mus-
cle pathology, myopathic changes and rimmed vacuoles can 
be found. According to previous studies, the general estimated 
incidence of LGMDs range from 1 to 6 out of 100000.1 Howev-
er, because of the heterogeneity of LGMDs, their prevalence is 
underestimated, and the frequency is likely to increase if more 
genetic and pathologic information accumulates. 
Our patients experienced gradually progressive weakness 
with various serum CK levels. They all had progressive limb-
girdle muscle weakness, and patient 3 also had bulbar symp-
toms. We discovered heterozygous missense mutation of the 
DNAJB6 gene on whole axon sequencing and target sequenc-
ing panel, including 191 genes associated with muscular dys-
trophies (c.265T>A for patient 1 and c.298T>A for patients 2 
and 3).
Unfortunately, we were unable to obtain genetic informa-
tion from the family of patient 1. However, her father, son, all of 
her siblings, and one nephew had progressive weakness th-
roughout their lifetime. This pedigree suggests that the disease 
is transmitted in an autosomal dominant inheritance pattern. 
Although patients with LGMD1D are predominantly charac-
terized by proximal muscle weakness, patient 3 had distal domi-
nant weakness and bulbar symptoms. Ruggieri, et al.3 reviewed 
the cases of five patients and conducted a formal study with LG-
MD1D patients. They found that proximal G/F domain muta-
tions (Phe89, Phe91, and Phe93) caused proximal limb-girdle 
weakness, while distal G/F mutations (Pro96 and Phe100) caus-
ed distal-onset weakness. Our patient also had distal G/F mu-
tations (Phe100).
In previous studies, p.Phe89Ile4,5 was identified as a patho-
genic mutation, and mutation of the 298th base pair in exon 5 
was reported in one case.3 Our patient, however, did not have 
the same missense mutation. One study reported a mutation of 
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Fig. 1. Radiologic and pathologic findings of muscular dystrophy pa-
tients. (A) Radiologic finding of patient 1. T2-weighted MRI shows mod-
erate fatty change in the tibialis posterior (arrowhead) and gastrocne-
mius (arrow). (B) Muscle biopsy in patient 3 shows rimmed vacuole 
findings (arrow) (hematoxylin and eosin stain, ×200),  scale bar, 50 μm.
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c.298T>G, and our study discovered a mutation of c.298T>A. 
The proteins synthesized also differed in valine and isoleucine 
residues. According to the criteria of American College of Medi-
cal Genetics and Genomics, a novel missense amino acid ch-
ange occurring at the same position as another pathogenic 
missense change is considered moderate evidence for being 
pathogenic.6 Also, this variant was not shown in controls in 
population frequency studies from the Exome Sequencing 
Project, 1000 Genomes Project, or Exome Aggregation Consor-
tium. Furthermore, mutations in the G/F domain have been 
indicated as possible mutations in previous studies. Based on 
this evidence for moderate pathogenicity, we concluded that 
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Fig. 2. Pedigree and electropherogram findings of three limb-girdle 
muscular dystrophy type 1D patients. (A) Pedigree of patient 1. (B) Elec-
tropherogram presents a mutation in DNAJB6 genomic DNA (c.265T>A; 
p.Phe89Ile). (C) Novel mutation in patient 2 and his father (his mother’s 
sequencing showed no variant in DNAJB6).
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this variant is likely pathogenic.
More than nine mutation sites in the DNAJB6 gene have been 
identified, including those in our study. Some of them, includ-
ing p.Phe91Ile, p.Phe93Leu, p.Pro96Arg, and p.Phe100Val, have 
been reported in European and American families.2-5,7 Some 
of them, such as p.Phe93Ile and p.Pro96Leu, have only been 
reported in Asian families.8-10 The mutations of p.Phe89Ile and 
p.Phe91Leu were reported in European, American, and Asian 
families. One of our cases had a mutation of p.Phe100Ile, which 
is a novel mutation that has not been reported before. The 
symptoms of patients do not appear to differ significantly be-
tween Eastern and Western countries.
The diagnosis of muscular dystrophy is difficult, and it is not 
easy to find the pathologic mutation. In addition to clinical 
symptoms, family history and serum CK levels should be con-
sidered. Continued reporting of clinical symptoms and genetic 
variation will be helpful in diagnosing these conditions. Here, 
we report three patients with LGMD1D from two families and 
one novel mutation in DNAJB6, p.Phe100Ile (c.298T>A).
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